bioRxivGenomicsPreprint
HASTER is a transcriptional stabilizer of HNF1A
Anthony BeucheriD, Irene Miguel-EscaladaiD, Diego BalboaiD, Matías G. De Vas, Miguel Angel Maestro, Javier García-HurtadoiD, Aina BernaliD, Roser Gonzalez-Franco, Pierfrancesco Vargiu, Holger HeyniD, Philippe RavassardiD, Sagrario OrtegaiD, Jorge P. FerreriD
Abstract
The biological purpose and disease relevance of long noncoding RNAs (lncRNAs) is poorly understood. We examined HASTER, a lncRNA antisense to HNF1A. Haploinsufficient mutations in HNF1A, encoding a homeodomain transcription factor, cause diabetes mellitus. Using mouse and human models, we show that HASTER maintains HNF1A at cell-specific physiological concentrations through positive and negative feedback loops. Haster mutant pancreatic {beta} cells thus showed variegated HNF1A overexpression or silencing, causing insulin-deficiency and diabetes. We demonstrate that the HASTER promoter acts in cis to prevent HNF1A overexpression and silencing, and link HASTER-dependent inhibition to local remodelling of 3D chromatin architecture. We further show that HASTER negative feedback ensures that HNF1A creates open chromatin at appropriate cell-specific genome regions. Our studies expose a cis-regulatory element that is unlike enhancers or silencers, and instead stabilizes expression levels of a pioneer transcription factor. They also show that disruption of a mammalian lncRNA can cause diabetes mellitus.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HNF1α transcriptional activation and repression maintain human islet α and β cell function
Mollie F. Qian, Romina J. Bevacqua, … Seung K. Kim·bioRxiv·Sep 25, 2022
- Structural properties of the HNF-1A transactivation domain
L. Kind, M. Driver, … P. Kursula·bioRxiv·Jun 23, 2023
- Human pancreatic β cell lncRNAs control cell-specific regulatory networks
İldem Akerman, Zhidong Tu, … Jorge P. Ferrer·Cell MetabolismPeer-reviewed·Dec 29, 2016
- Nuclear HMGB1 protects from non-alcoholic fatty liver diseases through negative regulation of liver X receptor
J. Personnaz, E. Piccolo, … J.-P. Pradere·bioRxiv·Feb 17, 2021
- Hammerhead-type FXR agonists induce an eRNA FincoR that ameliorates nonalcoholic steatohepatitis in mice
- Systemic identification of functionally conserved lncRNA metabolic regulators in human and mouse livers
Chengfei Jiang, Zhe Li, … Haiming Cao·GastroenterologyPeer-reviewed·Aug 10, 2024